Intervention Review

You have free access to this content

Chinese herbal medicines for hypertriglyceridaemia

  1. Zhao Lan Liu1,2,
  2. George Q Li2,
  3. Alan Bensoussan3,
  4. Hosen Kiat4,
  5. Kelvin Chan2,3,
  6. Jian Ping Liu1,*

Editorial Group: Cochrane Metabolic and Endocrine Disorders Group

Published Online: 6 JUN 2013

Assessed as up-to-date: 11 MAY 2012

DOI: 10.1002/14651858.CD009560.pub2


How to Cite

Liu ZL, Li GQ, Bensoussan A, Kiat H, Chan K, Liu JP. Chinese herbal medicines for hypertriglyceridaemia. Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD009560. DOI: 10.1002/14651858.CD009560.pub2.

Author Information

  1. 1

    Beijing University of Chinese Medicine, Centre for Evidence-Based Chinese Medicine, Beijing, China

  2. 2

    University of Sydney, Faculty of Pharmacy, Sydney, Australia

  3. 3

    University of Western Sydney, CompleMED, School of Science & Health, Sydney, NSW, Australia

  4. 4

    Cardiac Health Institute, The Australian School of Advanced Medicine, Macquarie University, Sydney, NSW, Australia

*Jian Ping Liu, Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, 11 Bei San Huan Dong Lu, Chaoyang District, Beijing, 100029, China. jianping_l@hotmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 6 JUN 2013

SEARCH

References

References to studies included in this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
Liu 2008 {published data only}
  • Liu YQ, Shi SQ, Zhao Y, Lu JS, Li YF, Yan WH, et al. Therapeutic effect of uric-acid-sequester herbal extract on the primary hyperuricemia and hypertriglyceridemia. Clinical Practice Medicine 2008;3(34):60-6.
Miao 2008 {published data only}
  • Miao GZ, Wang YJ, Cao PL, Zhu XM, Wang LQ, Miu Juan, et al. The clinical observation of integrative medicine for type 2 diabetes and hypertriglyceridaemia patients. Beijing Journal of Traditional Chinese Medicine 2008;27(6):458-9.
Tan 2010 {published data only}
  • Tan N, Huang SG, Zhou RY, Li DY, Zhu HJ. Clinical observation of Chushihuayu decoction on the treatment of hyperuricemia and hypertriglyceridemia. Chinese Journal of Information on Traditional Chinese Medicine 2010;17(3):9-11.

References to studies excluded from this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
Cui 2005 {published data only}
  • Cui AQ, Liu GR. The observation of clinical effectiveness of Lipi Tiaozhi capsule on hypertriglyceridaemia. Shandong Journal of Traditional Chinese Medicine 2005;24(7):398-9.
Feng 2004 {published data only}
  • Feng YY, Li NF. The observation on effectiveness and safety of Xuezhikang on hyperlipidaemia patients. Journal of Chinese Medicine Research 2004;4(10):883-5.
Li 2010 {published data only}
  • Li H. The observation of effectiveness of Tiedanxin soft capsule for hypertriglyceridaemia. Chinese Medicine Modern Distance 2010;8(16):79-80.
Lin 1999 {published data only}
  • Lin SM, Chen SW, Chen C. A clinical study of Guben Jiangzhi pill for old patients with hyperlipoproteinemia - with the data analysis of 160 cases. Acta Universitatis Traditionis Medicalis Sinensis Pharmacologiaeque Shanghai 1999;13(1):16-9.
Liu 2006 {published data only}
  • Liu YT, Wang ZY. The effectiveness of Cattail pollen capsule on 58 dyslipidaemia patients. Chinese Journals of Practical Medicine 2006;1(6):63-4.
Lv 2005 {published data only}
  • Lv SF, Cao KQ, Wang PY. The clinical observation of Modified Zexie decoction on hyperlipidaemia. Clinical Journal of Traditional Chinese Medicine 2005;17(5):454-5.
Yang 2009 {published data only}
  • Yang AN, Xu YX, Yang BP, Li D. 40 cases of familial hypertriglyceridaemia treated with Qiwu Taozhi granule. Gansu Journal of Traditional Chinese Medicine 2009;22(3):27-8.

Additional references

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
Anderson 2011
  • Anderson F, Mbatha SZ, Thomson SR. The early management of pancreatitis associated with hypertriglyceridaemia. South African Journal of Surgery 2011;49(2):82-4. [PUBMED: 21614978]
Barter 2006
  • Barter PJ, Rye KA. Cardioprotective properties of fibrates: which fibrate, which patients, what mechanism?. Circulation 2006; Vol. 113, issue 12:1553-5. [PUBMED: 16567579]
Beltowski 2009
  • Beltowski J, Wojcicka G, Jamroz-wisniewska A. Adverse effects of statins - mechanisms and consequences. Current Drug Safety 2009; Vol. 4, issue 3:209-28.
Chait 1992
Christian 2011
  • Christian JB, Bourgeois N, Snipes R, Lowe KA. Prevalence of severe (500 to 2,000 mg/dl) hypertriglyceridemia in United States adults. American Journal of Cardiology 2011;107(6):891-7. [PUBMED: 21247544]
Higgins 2002
Higgins 2003
Higgins 2011
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Hokanson 1996
  • Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. Journal of Cardiovascular Risk 1996;3(2):213-9. [PUBMED: 8836866]
ICH-GCP 1997
  • International Conference on Harmonisation Expert Working Group. Code of Federal Regulations & International Conference on Harmonisation Guidelines. Pennsylvania: Parexel/Barnett, 1997.
Jacobson 2009
  • Jacobson TA. Myopathy with statin-fibrate combination therapy: clinical considerations. Nature Reviews Endocrinology 2009; Vol. 5, issue 9:507-18.
Ji 2008
  • Ji W, Gong BQ. Hypolipidemic activity and mechanism of purified herbal extract of Salvia miltiorrhiza in hyperlipidemic rats. Journal of Ethnopharmacology 2008;119(2):291-8. [PUBMED: 18691646]
Jing 2009
  • Jing A, Li-Mei Z, Yan-Jie L, Ben-Zhi C, Yong Z, Bao-Feng Y. A randomized, multicentre, open-label, parallel-group trial to compare the efficacy and safety profile of daming capsule in patients with hypercholesterolemia. Phytotherapy Research 2009;23(7):1039-42.
Kjaergard 2001
  • Kjaergard LL, Villumsen J, Gluud C. Reported methodological quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine 2001;135(11):982-9.
Kumar 2005
Le 2007
  • Le NA, Walter MF. The role of hypertriglyceridemia in atherosclerosis. Current Atherosclerosis Reports 2007;9(2):110-5. [PUBMED: 17877919]
Li 2005
  • Li LM, Rao KQ, Kong LZ, Yao CH, Xiang HD, Zhai FY, et al. [A description on the Chinese national nutrition and health survey in 2002]. Zhonghua Liu Xing Bing Xue Za Zhi 2005;26(7):478-84. [PUBMED: 16334996]
Liberati 2009
  • Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic and meta-analyses of studies that evaluate interventions: explanation and elaboration. PLoS Medicine 1999;6(7):1-28. [DOI: 10.1371/journal.pmed.1000100]
Liu J 2006
  • Liu J, Zhang J, Shi Y, Grimsgaard S, Alraek T, Fonnebo V. Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials. Chinese Medical Journal 2006;23:1-4.
Martinez 2008
  • Martinez DP, Diaz JO, Bobes CM. Eruptive xanthomas and acute pancreatitis in a patient with hypertriglyceridemia. International Archives of Medicine 2008;1(1):6. [PUBMED: 18474088]
Moher 1998
  • Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998;352:609-13.
Mota 2004
  • Mota M, Panus C, Mota E, Lichiardopol C, Vladu D, Toma E. The metabolic syndrome - a multifaced disease. Romanian Journal of Internal Medicine 2004;42(2):247-55. [PUBMED: 15529615]
NCEP 2001
  • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsNational Cholesterol Education Program (NCEP). Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285(19):2486-97.
Pocock 1990
  • Pocock, S.J. Clinical Trials: A Practical Approach. John Wiley & Sons, UK, 1990.
Schulz 1995
  • Schulz KF, Chalmers I, Hayes R, Altman D. Empirical evidence of bias. JAMA 1995;273(5):408-12.
Sun 2009
  • Sun YC. Treatment of 60 cases of hypertriglyceridemia with Huayuchushisan. Shanxi Journal of Traditional Chinese Medicine 2009;30(9):1163.
Wang 2010
  • Wang YZ, Han XL. Clinical observation on hypertriglyceridemia treated by Yiqisanju formula in 24 patients. Hebei Journal of Traditional Chinese Medicine 2010;32(7):999.
Wei 2006
  • Wei ASH, Ye JH, Chen P, Jian KK, Liu T, Lang JM. Effects of Yinchenwulingsan on insulin resistance of hypertriglyceridemia patients. New Journal of Traditional Chinese Medicine 2006;38(11):44.
WHO 2000
  • WHO. Noncommunicable diseases in South-East Asia region: a profile. http://209.61.208.233/LinkFiles/NCD_InforBase_ncd-profile.pdf (accessed April 10, 2013).
Xing 2007
  • Xing Y, Yue P, Sun LH, Zhao WX, Wang Y, Zhang Y, et al. [Effect of Daming capsule on expression of connexin43 isoforms in hyperlipemic rat's cardiac muscle]. Zhongguo Zhong Yao Za Zhi 2007;32(14):1440-5. [PUBMED: 17966361]
Zhai 2007
  • Zhai ZS, Han XL. Treatment of 24 cases of hypertriglyceridemia with Buyang Huanwu decoction. Hebei Journal of Traditional Chinese Medicine 2007;29(9):807.
Zhang 2007
  • Zhang SJ, Cheng ZX, Lin YW, Qin J, Cheng YH, Liu SL. [Effection of composite salviae dropping pill on hyperlipemia patients with phlegm and blood stasis syndrome]. Zhongguo Zhong Yao Za Zhi 2007;32(5):440-3.
Zhang 2011
  • Zhang J, Dong Z, Li G, Jiao SF, Xie J, Zhou Y, et al. A cross-sectional study on risk factors of associated type 2 diabetes mellitus among adults in Beijing. Zhonghua Liu Xing Bing Xue Za Zhi 2011;32(4):357-60. [PUBMED: 21569666]